Fellows National Lipid Association Self-Assessment Program (NLA-SAP)

Curriculum:
N/A
Launch Date:
01-Sep-13
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

No primary audience was provided.

Relevant Terms:

No primary audience was provided.

1. Explain lipoprotein metabolism and its role in the pathogenesis of atherosclerosis
2. Identify the genetic causes of low and high serum HDL-C and LDL-C and the pathophysiologic implications of these disorders
3. Discuss the genetic causes of low and high serum triglycerides and the pathophysiologic implications of these disorders
4. Identify special patient populations at high cardiometabolic risk.
5. Identify traditional and emerging risk factors for the development of atherosclerotic vascular disease.
6. Outline the complexities of cardiometabolic risk management in patients who are overweight or obese.
7. Evaluate the use of biomarkers in the prevention and treatment of atherosclerosis.
8. Utilize effective treatment strategies for the management of multiple cardiometabolic risk factors.
9. Describe the pathophysiology of type-2 diabetes and metabolic syndrome, including the characteristics of atherogenic dyslipidemia found in these patients.
10. Review the role of subclinical atherosclerosis testing in cardiovascular disease risk assessment and management.
11. Review the role of blood biomarkers in cardiovascular disease risk assessment and management.
12. Outline current issues and approaches to global risk assessment.
13. Review the role of coronary CT angiography in cardiovascular disease risk assessment and management.
14. Describe effective diet and lifestyle strategies for long-term obesity and dyslipidemia management.
15. Review the mechanism of action of plant sterols/stanols and the role of these functional foods in the management of hypercholesterolemia.